Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy

Details for Australian Patent Application No. 2003255176 (hide)

Owner AstraZeneca AB The University Court of the University of Aberdeen

Inventors Cameron, Norman Eugene; Cotter, Mary Anne

Agent Davies Collison Cave

Pub. Number AU-B-2003255176

Parent 763970

Filing date 20 October 2003

Wipo publication date 13 November 2003

Acceptance publication date 2 November 2006

International Classifications

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/192 (2006.01)

A61K 31/22 (2006.01)

Event Publications

30 October 2003 Complete Application Filed

6 November 2003 Complete Application Filed

13 November 2003 Application Open to Public Inspection

  Published as AU-B-2003255176

2 November 2006 Application Accepted

  Published as AU-B-2003255176

1 March 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003255177-Use of neuronal sodium channel antagonists for the control of ectoparasites in homeothermic animals

2003255175-Fungicidally active compound combinations